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Median (10th-90th percentile) of age and estimated glomerular ﬁltration
rate (GFR) were 46 (24-69) and 64 (24-104). The analyzed data were: age,
gender, body mass index (BMI) serum albumin, creatinine, calcium and
phosphate; 24-h urine creatinine, phosphate (P),proteinuria (DP).
Estimated parameters includes: eGFR, fractional P excretion (FEP), 24-h P
excretion (24-h UP), and P clearance (CP). Dietary protein intake (DPI) was
based on 24-h urinary urea excretion. No signiﬁcant differences in serum
phosphate were found in groups with various DPI. FEP, 24-h UP and CP
were signiﬁcantly higher in higher DPI range. DPI was positively associated
with 24-h UP (b¼0,287, po0.000001) in multivariate model adjusted for
age, gender, DP, eGFR, serum P, FEP, BMI, and Ca. Thus, DPI is considered to
be the independent factor inﬂuencing urinary P excretion and hence
contributing to progression of mineral and bone disease in renal
dysfunction.
http://dx.doi.org/10.1016/j.krcp.2012.04.374
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PATIENT SATISFACTION AND DIETARY OUTCOMES FROM ATTENDING A
MULTIDISCIPLINARY CYSTINURIA CLINIC
Angela Doherty, Kathie Wong, Kay Thomas, Gosia Kamoga
Guy’s and St.Thomas’ Foundation Trust, London, England
Cystinuria is a genetic disease that leads to frequent cystine stone
formation. A reduced methionine (precursor to cystine) diet has been
recommended for cystinuria patients, involving maintenance of healthy
weight, limiting intake of animal protein and salt whilst increasing
vegetable protein, fruit, vegetables and ﬂuid intake. The ability of patients
to adhere to these dietary regimes has been questioned. We evaluated the
dietetic service and dietary changes within our multidisciplinary cystinuria
clinic using food frequency questionnaires (ffqs), dietary change
questionnaires (dcqs) and diet histories. Most patients were seen by the
dietitian 6–12 monthly.
100% of patients felt they beneﬁted from dietetic input. There was a
move away from ffqs due to them being difﬁcult and cumbersome to
complete. Dcqs and diet histories revealed 23/28 increased fruit and
vegetable intake, 20/28 decreased salt intake, 20/28 decreased animal
protein intake, 14/28 increased vegetable protein intake and 9/28
increased ﬂuid intake. There were a few discrepancies in reported change
between dcqs and diet histories, supporting the use of multi-source
feedback for diet analysis.
Patients had varying degrees of success with making changes to each
dietary parameter. Multi-source diet analysis allowed us to develop
tailored consultations. All patients made some positive dietary changes
which may help prevent stone formation. The areas of least change were
ﬂuid (due to changes made prior to clinic attendance) and vegetable
protein. Our results support the need for continued dietetic input. These
results should be re-audited to check that patients are maintaining the
changes made.
http://dx.doi.org/10.1016/j.krcp.2012.04.375
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EVALUATION OF NUTRITIONAL STATUS IN PERITONEAL DIALYSIS
(PD) PATIENTS
Max Dratwa 1, Christian Verger 2
aCHU Brugmann, Brussels, Belgium
bRDPLF, Pontoise, France
In 2009, analysis of the French Language Peritoneal Dialysis Registry
(RDPLF) data revealed that 6 patients out of 355 (1,7%) were transferred to
HD because of malnutrition after a median period of 31 months.
Furthermore, malnutrition was responsible for the death of 5.1 % patients
after a median period of 14 months. So, as nutritional status has been
shown to impact morbidity and mortality of dialysis patients, we set out to
measure this status in incident PD patients of 2 European centers using
various validated methods. The techniques used were:
anthropometric,BMI and biochemical measurements, SGA, Brandes score,
total (renal and peritoneal) creatinine excretion, dietician records, handgrip
strength, DEXA, multifrequency electrical bioimpedance (TBIA). Daily
dietary protein intake was less than 1g/kg ideal BW in 35 % of pts while
38% ate more than 1.2 g/kg; daily total (oral and peritoneal) caloric intake
was 2878 kcal/kg. Fifteen % of patients (median age 71) had a very low
serum albumin level (o30 g/l) while 50 % maintained their albumins 4
50 g/l (median age 64 years). Very signiﬁcant correlations were found
between: 1) estimation of fat mass by skinfold thickness and that
modelised from the water volume determined by TBIA (r2: 0.56,
po0.0001); 2) brachial circumference and lean body mass determined by
TBIA (but no correlation between middle arm circumference and handgrip
strength) ; 3) muscle mass determined by creatinine kinetics and TBIA (r2:
0.68, po0.001); 4) muscle mass estimated by brachial circumference and
lean body mass estimated through creatinine kinetics; 5) handgrip
strength and lean body mass determined both by TBIA and by creatinine
kinetics (r2: 0.59, po0.0001); 6) lean body mass and age (but different
between males and females); 7) protein losses in the dialysate and lean
body mass derived from creatinine kinetics. In conclusion, malnutrition is
more threatening as patients age. Patients with a low initial lean body
mass and low protein intakes should be closely monitored such as protein
losses do not counterbalance the theoretical advantages of a higher
dialysis dose.
http://dx.doi.org/10.1016/j.krcp.2012.04.376
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ALDOSTERONE AND CORTISOL AFFECT THE RISK OF SUDDEN CARDIAC
DEATH IN HEMODIALYSIS PATIENTS
Background: Sudden cardiac death is common and accounts to a large
extent for the excess mortality of patients on maintenance dialysis. It is
unknown whether aldosterone and cortisol increase the incidence of
sudden cardiac death in dialysis patients.
Methods: We analyzed data from 1255 hemodialysis patients with type
2 diabetes mellitus, participating in the German Diabetes and Dialysis
Study (4D Study). Aldosterone (o15 pg/mL; 15–100 pg/mL, 100–200 pg/
mL, 4200 pg/mL), and cortisol (quartiles) were determined at baseline and
patients were followed up for a median of 4 years. By Cox regression
analyses hazard ratios (HR) were determined for the effect of aldosterone,
cortisol and its combination on sudden death and other cardiovascular
outcomes.
Results: The mean age of the patients was 6678 years (54% male). The
median levels of aldosterone was 15 pg/mL and of cortisol 16.8 mg/dL.
Patients with aldosterone levels 4200 pg/mL had a signiﬁcantly higher
risk of sudden death (HR 1.69; 95% CI 1.06-2.69) compared to those with an
aldosterone o15 pg/mL. The combined presence of high aldosterone
(4200 pg/mL) and high cortisol (421.1 mg/dL) levels increased the risk of
sudden cardiac death strikingly compared to patients with low aldosterone
(o15 pg/mL) and low cortisol (o13.2 mg/dl) levels (HR 2.86, 95% CI 1.32-
6.21). Furthermore, all-cause mortality was signiﬁcantly increased in the
patients with high levels of both hormones (HR 1.62, 95% CI 1.01-2.62).
Conclusions: The joint presence of high aldosterone and high cortisol levels
strongly increased the incidence of sudden cardiac death as well as all-
cause mortality in hemodialyzed type 2 diabetic patients. Whether
blockade of the mineralocorticoid receptor decreases the risk of sudden
death without causing side effects must be examined in future trials.
http://dx.doi.org/10.1016/j.krcp.2012.04.377
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CHRONIC KIDNEY DISEASE IN ADULTS WITH THE METABOLIC
SYNDROME IN BENIN CITY: PREVALENCE AND CORRELATES.
Oghenekaro Egbi 1, Evelyn Unuigbe.I 2, Efosa Oviasu 2, Louis Ojogwu 1,2
1 Department of Medicine, Federal Medical Centre,Yenagoa,Bayelsa State,
Nigeria
2 Department of Medicine, University of Benin Teaching Hospital, Benin City,
Nigeria
The Metabolic Syndrome (MetS) is a constellation of interrelated risk
factors that appear to directly promote the development of atherosclerotic
cardiovascular disease. Recently, an association with chronic kidney
disease (CKD) has been documented severally in literature. Only a few
prevalence studies on MetS exist in this part of the world. The aims of the
study were to determine the prevalence of CKD in patients with MetS and
to determine the association between MetS- related variables and CKD. The
updated NCEP ATP III guideline was used for deﬁnition of MetS. Patients
had their fasting plasma glucose, serum lipids, urea and creatinine as well
as spot urine albumin: creatinine ratio done. Two hundred and twenty two
patients completed the study. The prevalence of CKD was 20.3% while
20.0% had abnormal ACR value. Body mass index (BMI), waist/hip ratio,
diastolic blood pressure, total cholesterol and LDL-cholesterol were
associated with CKD in univariate analysis but only BMI and diastolic blood
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pressure were independent predictors of CKD in multivariate analysis.
There was a graded relationship between the number of MetS traits and the
presence of CKD and also between MetS traits and ACR.
In conclusion, CKD is prevalent in patients with the metabolic syndrome
and may be due to a synergistic effect of the various components of the
syndrome. Diastolic blood pressure and obesity may predict CKD in MetS
patients. Albuminuria may also be prevalent in MetS patients; increasing
with increasing number of MetS traits.
http://dx.doi.org/10.1016/j.krcp.2012.04.378
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PREVALENCE OF HOSPITAL MALNUTRITION IN RENAL PATIENTS
Atilano-Carsi X., Campos-Collado AX., Miranda-Alatriste P, Leyva-
Rendon F., Rosas-Jimenez M., Correa-Rotter R, Espinosa-Cuevas MA.n
Depto. Nefrologa y Metabolismo Mineral. Instituto Nacional de Ciencias
Medicas y Nutricion ‘‘Salvador Zubiran’’, Mexico, D.F
The prevalence of protein energy wasting varies enormously depending
on deﬁnition and parameters used. Most evidence include clinical stable
patients only. There is few evidence in pre dialysis patients. The purpose of
this study was to assess nutritional status at hospital admittance of renal
patients NKF-DOQI 2–5 predialysis and dialysis patients and its association
with morbidity and mortality. Nutritional assessment was done during the
ﬁrst three days of admission to the hospital with a composite nutritional
index in 907 renal patients (589 pre dialysis and 318 dialysis). Length of
stay and frequency of hospitalizations, mortality and comorbidities were
registered. ANOVA, Cox and Kaplan-Meier statistics were done where
needed. A prevalence of 76% of moderate to severe malnutrition was found
to the general population being more prevalente in dialysis patients (81%
dialysis vs 73% pre dialysis) (pr0.05). Hazard ration of malnutrition was
2.07 and 2.57 in DOQI 4 and 5 non dialysis patients respectively (po0.05).
Hazard ratio of mortality was 2.91 and 8.67 in moderate and severe
malnutrition respectively predialysis patients (po0.05) and 2.72 and 3.22
in moderate and severe malnutrition respectively in dialysis patients
(po0.05). Survival during the follow up was inferior in severe malnutrition
in both groups (po0.05). In conclusion a prevalence of 76% of malnutrition
was found in this cohort of hospitalized renal patients, greater than
reported elsewhere being in dialysis patients more prevalent. Malnutrition
was negatively associated with survival.
nCorresponding author.
http://dx.doi.org/10.1016/j.krcp.2012.04.379
56
CALCINEURIN A (CA) INHIBITION SUPRESSES PROTEIN SYNTHESIS VIA
AMP DEPENDENT KINASE (AMPK).
H. Franch, C. Ding, S. Zoromsky, S. Williams, J. Gooch
Atlanta VAMC & Emory University, Decatur & Atlanta, GA, USA.
Diabetes stimulates CA activity in the kidney and CA inhibitor
cyclosporine A (CYA) or CAb isoform knock-out (CAb -/-) block diabetic
renal hypertrophy.CA regulates the mammalian target of rapamycin
(mTOR) to reduce protein synthesis (PS) during cardiac hypertrophy.To
study this pathway, NRK-52E and SV40 transformed CAb þ/þ and -/-
proximal tubule cell lines were treated with 10 nM epidermal growth
factor (EGF) and/or 8 mM CYA. After 48 hrs of CYA in NRK-52E cells, EGF-
induced protein/well was 3074% lower with decreased PS (4972%) rather
than increased protein breakdown. In CAb -/- cells, protein/well (20þ2%)
and PS (16 71%) were lower and CYA did not decrease PS further. In
CAbþ/þ cells, CYA reduced PS 20þ2%. However, CYA did not block mTOR
signaling as measured by phosphorylation (P) at S2448 or by p70S6 kinase
P at T389. CYA also did not alter the mTOR dependent pathway of
macroautophagy. However, CYA in NRK-52E or CAb -/- cells showed
increased activation of the metformin-sensitive energy sensor, AMPK, as
measured by P of T172 by 5- or410-fold, respectively. AMPK reduces PS
via P of eukaryotic elongation factor 2 (eEF2) at T356 and CYA increased
eEF2 P by3 fold.We conclude CA inhibition reduces PS in renal
hypertrophy via a novel pathway involving AMPK and eEF2 rather than by
mTOR and p70S6 kinase. Activation of AMPK or altered energy metabolism
via CAb may be important in CA inhibitor nephrotoxicity.
http://dx.doi.org/10.1016/j.krcp.2012.04.380
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HIGH PROTEIN DIETS STIMULATE RENAL PROTEIN OXIDATION IN
EXPERIMENTAL DIABETES.
H. Franch, S. Zoromsky, S. Williams, C. Din
Atlanta VAMC & Emory University, Decatur & Atlanta, GA, USA.
Calorie restriction increases macro- and chaperone-mediated autophagy
(MA & CMA) protecting against organ damage by destroying oxidized
proteins (OX) and p62/sequestisome 1 labeled aggregates (p62). Altering
dietary protein changes kidney damage in DM, but the effect on renal
cortical MA, CMA, OX and p62 is unknown. 60 mg/kg streptozotocin
Diabetic (D) Sprague-Dawley rats (200 g) or control (C) were fed isocaloric
12% (L), 23% (M) or 40% (H) protein diets for 21 days (6 groups, each n¼
7-11). Body weight at 21 days was 16-22% lower than C in all D rats
(po0.01, NS between diets). Blood glucose was lower in DH vs. DL diets
(408þ25vs. 482þ23 mg/dl, po0.05). Kidney wt/body wt increased in all
DM groups, but increase was greater in DH than DL (104þ13 vs. 66þ11%,
po0.02). MA, CMA, and p62 were estimated by western blotting for light
chain 3b II/I ratio, lysosome associated membrane protein 2a, and p62
respectively, while OX was measured by Oxyblot. D reduced CMA by 65-
76% (po0.05 vs. C) while H diet reduced it by 45% in C and D rats (NS).
MA increased in all D, but was 10 fold higher in HD vs. HC or LD
(po0.02). There was a trend toward increased OX with D, but only HD
reached signiﬁcance vs. all C (95þ32%, po0.05). The trend for p62 to
increase with D or H was NS. We conclude that despite lower glucose, H
diets worsen diabetic renal hypertrophy and cortical OX possibly by
suppressing CMA. Increases in MA by D and H prevent p62 protein
aggregates from accumulating.
http://dx.doi.org/10.1016/j.krcp.2012.04.381
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SERUM OMEGA-3 FATTY ACID LEVELS IN A LARGE INCIDENT U.S.
HEMODIALYSIS POPULATION
Allon Friedman, MD1, Zhangsheng Yu 1, Rebecca Tabbey 1, Cheryl Denski 1,
Ravi Thadhani 2, Yong Li 3, Bruce Watkins 3
1
Indiana University, Indianapolis, IN, USA
2
Massachusetts General Hospital, Boston, MA, USA
3
University of Connecticut, Storrs, CT, USA
Long chain omega-3 (n-3 PUFA) fatty acids may inﬂuence clinical outcomes
in hemodialysis patients. We therefore performed the largest characterization
to date of n-3 PUFA levels in an incident hemodialysis population.
Serum n-3 PUFA were measured in samples obtained at baseline in a 400
person subgroup of the ArMORR study, a large representative cohort of U.S.
incident hemodialysis patients. n-3 PUFA were measured by gas
chromatography, with phospholipid (PL) and triglyceride (TG) fatty acids being
separated by solid phase extraction. Signed rank test was used to compare PL
and TG fractions.
Mean (7SD) age was 66714 years and body mass index 2677 kg/m2.
58% were men and 68% white. Cause of ESRD was diabetes and hypertension in
47% and 40% of subjects, respectively. Total serum 20:5n-3 (EPA) (by mean
weight %) was 0.0970.36 (PL vs. TG: 0.0970.43 vs. 0.0770.30, p¼0.14), and
total serum 22:6n-3 (DHA) was 1.4670.72 (PL vs. TG: 3.0371.24 vs.
0.2170.40, po0.001). Minimal 22:5n-3 (DPA) was detected. Total long chain
n-3 PUFA levels were 1.5570.95 (PL vs TG: 3.1371.47 vs. 0.2870.64,
po0.001).
In summary, n-3 PUFA levels in this large U.S. cohort are low relative to
published reports of levels in the general population or even in hemodialysis
patients outside the U.S., making this a potential target for intervention.1 In
addition, future enquiries into n-3 PUFA in hemodialysis cohorts should focus
on the phospholipid fraction since we have demonstrated that, similar to the
general population, this is where they primarily accumulate.
http://dx.doi.org/10.1016/j.krcp.2012.04.382
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